cbdMD Capital Expenditures (CapEx) Growth & History (YCBD)
cbdMD's capital expenditures (capex) was $184,172 for fiscal 2025.
View full cbdMD company overviewcbdMD annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $184,172 | −$5,843 | −3.08% |
| 2024 | 2024-09-30 | $190,015 | −$107,534 | −36.14% |
| 2023 | 2023-09-30 | $297,549 | −$391,131 | −56.79% |
| 2022 | 2022-09-30 | $688,680 | $346,667 | +101.36% |
| 2021 | 2021-09-30 | $342,013 | −$978,082 | −74.09% |
| 2020 | 2020-09-30 | $1.3M | $121,477 | +10.13% |
| 2019 | 2019-09-30 | $1.2M | $1.2M | +4987.73% |
| 2018 | 2018-09-30 | $23,559 | $15,592 | +195.71% |
| 2017 | 2017-09-30 | $7,967 | −$119,292 | −93.74% |
| 2016 | 2016-09-30 | $127,259 | — | — |
cbdMD quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $18,065 | $16,590 | +1124.75% |
| Q2 2026 | 2026-03-31 | $5,748 | −$9,758 | −62.93% |
| Q1 2026 | 2025-12-31 | $164,802 | $415 | +0.25% |
| Q4 2025 | 2025-09-30 | $2,804 | −$7,196 | −71.96% |
| Q3 2025 | 2025-06-30 | $1,475 | $1,475 | — |
| Q2 2025 | 2025-03-31 | $15,506 | $10,886 | +235.63% |
| Q1 2025 | 2024-12-31 | $164,387 | −$20,248 | −10.97% |
| Q4 2024 | 2024-09-30 | $10,000 | −$110,180 | −91.68% |
| Q3 2024 | 2024-06-30 | $0 | −$102,389 | — |
| Q2 2024 | 2024-03-31 | $4,620 | −$97,770 | −95.49% |
| Q1 2024 | 2023-12-31 | $184,635 | $7,265 | +4.10% |
| Q4 2023 | 2023-09-30 | $120,180 | −$106,279 | −46.93% |
| Q3 2023 | 2023-06-30 | $102,389 | $13,963 | +15.79% |
| Q2 2023 | 2023-03-31 | $102,390 | −$40,375 | −28.28% |
| Q1 2023 | 2022-12-31 | $177,370 | −$53,660 | −23.23% |
| Q4 2022 | 2022-09-30 | $226,459 | $196,018 | +643.93% |
| Q3 2022 | 2022-06-30 | $88,426 | $3,396 | +3.99% |
| Q2 2022 | 2022-03-31 | $142,765 | $9,517 | +7.14% |
| Q1 2022 | 2021-12-31 | $231,030 | $137,736 | +147.64% |
| Q4 2021 | 2021-09-30 | $30,441 | −$501,210 | −94.27% |
| Q3 2021 | 2021-06-30 | $85,030 | $29,630 | +53.48% |
| Q2 2021 | 2021-03-31 | $133,248 | −$1.1M | −89.26% |
| Q1 2021 | 2020-12-31 | $93,294 | −$462,380 | −83.21% |
| Q4 2020 | 2020-09-30 | $531,651 | −$307,546 | −36.65% |
| Q3 2020 | 2020-06-30 | $55,400 | −$201,817 | −78.46% |
| Q2 2020 | 2020-03-31 | $1.2M | $1.1M | +1244.48% |
| Q1 2020 | 2019-12-31 | $555,674 | $545,749 | +5498.73% |
| Q4 2019 | 2019-09-30 | $839,197 | $818,103 | +3878.37% |
| Q3 2019 | 2019-06-30 | $257,217 | $257,217 | — |
| Q2 2019 | 2019-03-31 | $92,279 | $92,079 | +46039.50% |
| Q1 2019 | 2018-12-31 | $9,925 | $7,260 | +272.42% |
| Q4 2018 | 2018-09-30 | $21,094 | $14,043 | +199.16% |
| Q3 2018 | 2018-06-30 | $0 | $0 | — |
| Q2 2018 | 2018-03-31 | $200 | −$7,784 | −97.49% |
| Q1 2018 | 2017-12-31 | $2,665 | −$4,369 | −62.11% |
| Q4 2017 | 2017-09-30 | $7,051 | — | — |
| Q3 2017 | 2017-06-30 | $0 | — | — |
| Q2 2017 | 2017-03-31 | $7,984 | — | — |
| Q1 2017 | 2016-12-31 | $7,034 | — | — |
cbdMD capital expenditures (capex) trends
Over the last five fiscal years, cbdMD's capital expenditures (capex) decreased from $1.3M to $184,172, a change of −$1.1M. The latest reported quarter, Q3 2026, shows $18,065.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review cbdMD source filings ↗